Insider · CIK 0001716033
Faisal Ghiath Sukhtian
Files at OTLK (Outlook Therapeutics, Inc.). First filing May 27, 2026, latest Jul 29, 2026.
In brief
Faisal Ghiath Sukhtian files SEC Form 4 as director at OTLK (Outlook Therapeutics, Inc.). Since May 27, 2026, Faisal Ghiath Sukhtian has reported 2 open-market buys worth $150k and 0 open-market sells worth $0, the latest filed on Jul 29, 2026.
A track record needs three past buys with six months of prices behind them; Faisal Ghiath Sukhtian has 0, so none is measured yet.
The newest scored trade: bought $100k of OTLK on Jul 29, 2026, filed Jul 29, 2026, scored 48 (moderate). In the last 12 months: 2 buys worth $150k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OTLK: Outlook Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Outlook Therapeutics, Inc. | $100k 95,398 shares | +76% | - | |
| 47Moderate | Outlook Therapeutics, Inc. | $50k 122,174 shares | +3593% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Common Stock | +95,398 | $1.05 | $100k | 220,972 | Jul 29, 2026 |
| May 27, 2026 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Common Stock | +122,174 | $0.41 | $50k | 125,574 | May 27, 2026 |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +286,734 | $0.00 | $0 | 286,734 | Oct 3, 2025 |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +117,296 | $0.00 | $0 | 117,296 | Oct 3, 2025 |
Questions about Faisal Ghiath Sukhtian
Answered from the filings on this page, as of the latest one.
Is Faisal Ghiath Sukhtian buying or selling?
In the last 12 months Faisal Ghiath Sukhtian reported 2 open-market buys worth $150k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of OTLK on Jul 29, 2026. Grants, option exercises and tax withholding are not counted.
How did Faisal Ghiath Sukhtian's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Faisal Ghiath Sukhtian has 0.
Where does Faisal Ghiath Sukhtian file Form 4?
Faisal Ghiath Sukhtian has filed Form 4 at OTLK (Outlook Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.